Syra Health Corp. Class A Common Stock (SYRA) Earnings History
Annual and quarterly earnings data from 2020 to 2025
Loading earnings history...
SYRA EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
SYRA Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 34.4% | -12.5% | -12.4% |
| 2024 | 20.7% | -47.2% | -47.1% |
| 2023 | 25.5% | -52.4% | -53.3% |
| 2022 | 18.9% | -37.2% | -37.7% |
| 2021 | 30.5% | -0.2% | -0.2% |
Download Data
Export SYRA earnings history in CSV or JSON format
Free sign-in required to download data
Syra Health Corp. Class A Common Stock (SYRA) Earnings Overview
As of May 8, 2026, Syra Health Corp. Class A Common Stock (SYRA) reported trailing twelve-month net income of -$183,089, reflecting +85.5% year-over-year growth. The company earned $-0.01 per diluted share over the past four quarters, with a net profit margin of -12.4%.
Looking at the long-term picture, SYRA's historical earnings data spans multiple years. The company achieved its highest annual net income of -$3,280 in fiscal 2021.
Syra Health Corp. Class A Common Stock is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including TALK ($8M net income, 3.4% margin), ACMR ($94M net income, 10.4% margin), CLOV (-$57M net income, -4.4% margin), SYRA has room to improve margins relative to the peer group. Compare SYRA vs TALK →
SYRA Earnings vs Peers
Earnings metrics vs comparable public companies
SYRA Historical Earnings Data (2020–2025)
6 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $-896,333 | +76.2% | $-904,324 | $-0.08 | -12.4% | -12.5% |
| 2024 | -$4M | -27.9% | -$4M | $-0.52 | -47.1% | -47.2% |
| 2023 | -$3M | -38.7% | -$3M | $-0.60 | -53.3% | -52.4% |
| 2022 | -$2M | -64478.2% | -$2M | $-0.29 | -37.7% | -37.2% |
| 2021 | $-3,280 | +23.1% | $-3,280 | $-0.00 | -0.2% | -0.2% |
| 2020 | $-4,267 | - | $-4,267 | $-0.00 | - | - |
See SYRA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SYRA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SYRA vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonSYRA — Frequently Asked Questions
Quick answers to the most common questions about buying SYRA stock.
Is SYRA growing earnings?
SYRA EPS is $-0.01, with earnings growth accelerating to +85.5%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-183089.00.
What are SYRA's profit margins?
Syra Health Corp. Class A Common Stock net margin is -12.4%, with operating margin at -12.5%. Below-average margins reflect competitive or cost pressures.
How consistent are SYRA's earnings?
SYRA earnings data spans 2020-2025. The accelerating earnings trend is +85.5% YoY. Historical data enables comparison across business cycles.